Literature DB >> 16503154

Quantification of phosphorylation of insulin receptor substrate-1 by HPLC-ESI-MS/MS.

Zhengping Yi1, Moulun Luo1, Lawrence J Mandarino2,3, Sara M Reyna4, Christopher A Carroll5, Susan T Weintraub5.   

Abstract

Serine/threonine phosphorylation of insulin receptor substrate-1 (IRS-1) regulates the function and subsequent insulin signaling of this protein. Human IRS-1 has 1242 amino acid residues, including 182 serines and 60 threonines. The size, complexity, and relatively low abundance of this protein in biological samples make it difficult to map and quantify phosphorylation sites by conventional means. A mass spectrometry peak area based quantification approach has been developed and applied to assess the relative abundance of IRS-1 phosphorylation in the absence or presence of stimuli. In this method, the peak area for a phosphopeptide of interest is normalized against the average of peak areas for six selected representative IRS-1 peptides that serve as endogenous internal standards. Relative quantification of each phosphopeptide is then obtained by comparing the normalized peak area ratios for untreated and treated samples. Two non-IRS-1 peptides were added to each digest for use as HPLC retention time markers and additional standards as well as references to the relative quantity of IRS-1 in different samples. This approach does not require isotopic or chemical labeling and can be applied to various cell lines and tissues. Using this method, we assessed the relative changes in the quantities of two tryptic phosphopeptides isolated from human IRS-1 expressed in L6 cells incubated in the absence or presence of insulin or tumor necrosis factor-alpha. Substantial increases of phosphorylation were observed for Thr(446) upon stimulation. In contrast, no obvious change in the level of phosphorylation was observed for Ser(1078). This mass spectrometry based strategy provides a powerful means to quantify changes in the relative phosphorylation of peptides in response to various stimuli in a complex, low-abundance protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503154     DOI: 10.1016/j.jasms.2005.12.010

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  30 in total

1.  Accurate quantitation of protein expression and site-specific phosphorylation.

Authors:  Y Oda; K Huang; F R Cross; D Cowburn; B T Chait
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.

Authors:  K Egawa; N Nakashima; P M Sharma; H Maegawa; Y Nagai; A Kashiwagi; R Kikkawa; J M Olefsky
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

Review 3.  Advances in protein complex analysis using mass spectrometry.

Authors:  Anne-Claude Gingras; Ruedi Aebersold; Brian Raught
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

4.  The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

Authors:  Donald S Kirkpatrick; Scott A Gerber; Steven P Gygi
Journal:  Methods       Date:  2005-01-12       Impact factor: 3.608

5.  Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation.

Authors:  Michael W Greene; Robert S Garofalo
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

Review 6.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

7.  Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance.

Authors:  Jeong-a Kim; Deborah C Yeh; Marel Ver; Yunhua Li; Andrea Carranza; Thomas P Conrads; Timothy D Veenstra; Maureen A Harrington; Michael J Quon
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

8.  Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.

Authors:  Moulun Luo; Sara Reyna; Lishan Wang; ZhengPing Yi; Christopher Carroll; Lily Q Dong; Paul Langlais; Susan T Weintraub; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2005-07-14       Impact factor: 4.736

9.  In vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-zeta: functional analysis and identification of novel phosphorylation sites.

Authors:  Mark R Sommerfeld; Sabine Metzger; Magdalene Stosik; Norbert Tennagels; Jürgen Eckel
Journal:  Biochemistry       Date:  2004-05-18       Impact factor: 3.162

10.  Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II.

Authors:  M J Tanasijevic; M G Myers; R S Thoma; D L Crimmins; M F White; D B Sacks
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

View more
  17 in total

1.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

2.  Label-free relative quantification of co-eluting isobaric phosphopeptides of insulin receptor substrate-1 by HPLC-ESI-MS/MS.

Authors:  Paul Langlais; Lawrence J Mandarino; Zhengping Yi
Journal:  J Am Soc Mass Spectrom       Date:  2010-06-09       Impact factor: 3.109

3.  Adenine nucleotide translocase is acetylated in vivo in human muscle: Modeling predicts a decreased ADP affinity and altered control of oxidative phosphorylation.

Authors:  Clinton Mielke; Natalie Lefort; Carrie G McLean; Jeanine M Cordova; Paul R Langlais; Andrew J Bordner; Jerez A Te; S Banu Ozkan; Wayne T Willis; Lawrence J Mandarino
Journal:  Biochemistry       Date:  2014-06-09       Impact factor: 3.162

4.  Enhancement of ionization efficiency and selective enrichment of phosphorylated peptides from complex protein mixtures using a reversible poly-histidine tag.

Authors:  Pegah R Jalili; Deepti Sharma; Haydn L Ball
Journal:  J Am Soc Mass Spectrom       Date:  2007-02-22       Impact factor: 3.109

5.  The identification of raptor as a substrate for p44/42 MAPK.

Authors:  Paul Langlais; Zhengping Yi; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2011-02-15       Impact factor: 4.736

6.  Burn injury-induced IRS-1 degradation in mouse skeletal muscle.

Authors:  X-M Lu; Rg Tompkins; Aj Fischman
Journal:  Int J Burns Trauma       Date:  2013-01-24

7.  Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle.

Authors:  K Højlund; Z Yi; N Lefort; P Langlais; B Bowen; K Levin; H Beck-Nielsen; L J Mandarino
Journal:  Diabetologia       Date:  2009-12-12       Impact factor: 10.122

8.  Novel reversible biotinylated probe for the selective enrichment of phosphorylated peptides from complex mixtures.

Authors:  Pegah R Jalili; Haydn L Ball
Journal:  J Am Soc Mass Spectrom       Date:  2008-02-26       Impact factor: 3.109

9.  Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells.

Authors:  Cora Weigert; Matthias Kron; Hubert Kalbacher; Ann Kathrin Pohl; Heike Runge; Hans-Ulrich Häring; Erwin Schleicher; Rainer Lehmann
Journal:  Mol Endocrinol       Date:  2008-10-16

10.  Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling.

Authors:  Moulun Luo; Paul Langlais; Zhengping Yi; Natalie Lefort; Elena A De Filippis; Hyonson Hwang; Christine Y Christ-Roberts; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.